Opinion - (2024) Volume 8, Issue 4
Thyroid Autoimmunity: Pathophysiology, Diagnosis and Emerging Therapies
Ryann Maria*
*Correspondence:
Ryann Maria, Department of Pathology, Boston Children’s Hospital,
USA,
Email:
1Department of Pathology, Boston Children’s Hospital, USA
, Manuscript No. rtr-25-160647;
, DOI: 10.37421/2684-4273.2024.8.95
Citation: Maria, Ryann. “Thyroid Autoimmunity: Pathophysiology, Diagnosis and Emerging Therapies.” Rep Thyroid Res 8 (2024): 95.
Copyright: © 2024 Maria R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Introduction
Cerebrospinal fluid is a clear, colorless fluid that surrounds the brain
and spinal cord, providing essential nutrients and removing waste products
from the central nervous system. CSF composition reflects the metabolic and
physiological status of the brain, making it a valuable source for biomarker
discovery and understanding neurological diseases. In this article, we explore
the use of enhanced mass spectrometry techniques for the identification
of polar metabolites and thyroid hormones in rodent CSF, highlighting their
potential applications in neuroscience research. CSF analysis plays a crucial
role in neuroscience research, as it provides valuable insights into the
metabolic processes and hormone levels within the central nervous system.
CSF is in direct contact with the extracellular space of the brain, making it an
ideal fluid for monitoring changes in brain metabolism and hormone levels.
Alterations in CSF composition have been linked to various neurological
disorders, including Alzheimer's disease, Parkinson's disease, and multiple
sclerosis. Analyzing polar metabolites and thyroid hormones in CSF poses
several challenges due to their low abundance and high chemical diversity.
Traditional analytical techniques, such as liquid chromatography-mass
spectrometry and gas chromatography-mass spectrometry, have limitations in
terms of sensitivity, selectivity, and coverage of metabolites and hormones.
Enhanced MS techniques, such as high-resolution MS and tandem MS,
offer improved sensitivity, resolution, and coverage, making them ideal
for analyzing complex biological samples like CSF. In a murine model of
Alzheimer's disease, enhanced MS analysis of CSF can identify alterations in
amino acid and neurotransmitter levels, shedding light on the metabolic and
neurochemical changes underlying cognitive decline. For example, increased
levels of glutamate and decreased levels of GABA may indicate excitotoxicity
and impaired inhibitory neurotransmission [1].
Description
HR-MS offers higher mass resolution and mass accuracy compared to
conventional MS, allowing for the detection and identification of metabolites
and hormones at low concentrations in CSF. HR-MS can distinguish between
compounds with similar mass-to-charge ratios, providing more accurate
identification. MS/MS allows for the fragmentation of analyte molecules,
providing structural information that can be used for identification. By
comparing the fragmentation patterns of unknown compounds to reference
spectra, metabolites and hormones in CSF can be identified with high
confidence. Hyphenated techniques, such as LC-MS and GC-MS, combine
separation techniques with MS, enabling the analysis of complex mixtures in
CSF. LC-MS is particularly useful for analyzing polar metabolites, while GCMS is more suitable for volatile compounds. Enhanced MS techniques have
been used to identify potential biomarkers for neurological diseases in CSF.
By comparing the metabolite and hormone profiles of healthy individuals to
those with neurological disorders, researchers can identify biomarkers that
may indicate disease progression or response to treatment. Enhanced MS
techniques are valuable for studying the pharmacokinetics of drugs in CSF.
By monitoring the levels of drugs and their metabolites in CSF over time,
researchers can determine drug distribution, metabolism, and elimination in
the central nervous system. CSF analysis using enhanced MS techniques
can provide insights into nutrient uptake and metabolism in the brain. This
information is crucial for understanding the metabolic processes that support
brain function and health [2].
Conclusion
Enhanced MS techniques have revolutionized the analysis of polar
metabolites and thyroid hormones in rodent CSF, offering improved sensitivity,
selectivity, and coverage compared to traditional analytical techniques.
These techniques have enabled researchers to identify novel biomarkers,
study drug pharmacokinetics, and monitor nutrient metabolism in the central
nervous system. Continued advancements in MS technology are expected
to further enhance our understanding of brain metabolism and neurological
disorders. Enhanced mass spectrometry techniques have revolutionized the
identification and quantification of polar metabolites and thyroid hormones
in rodent CSF. These advancements provide critical insights into the
neurochemical and metabolic changes associated with CNS disorders.
By improving our understanding of these processes, MS-based analyses
hold promise for advancing clinical diagnostics, therapeutic monitoring, and
personalized medicine in the field of neurology. As research continues to
evolve, the application of these techniques will undoubtedly enhance our ability
to diagnose, treat, and understand CNS diseases. In a hyperthyroid rodent
model, MS techniques can measure changes in thyroid hormone levels in
CSF, providing insights into the impact of thyroid dysfunction on brain function.
Elevated T4 and T3 levels in CSF may correlate with cognitive impairments
and neurochemical imbalances observed in hyperthyroidism.
References
Google Scholar , Crossref, Indexed at
Google Scholar , Crossref, Indexed at
- Imaoka, Tatsuhiko, Mayumi Nishimura, Daisuke Iizuka and Kazuhiro Daino et al. "Radiation-induced mammary carcinogenesis in rodent models: What's different from chemical carcinogenesis?" J Radiat Res 50 (2009): 281-293.
- Schreiber, Robert D., Lloyd J. Old and Mark J. Smyth. "Cancer immunoediting: Integrating immunity’s roles in cancer suppression and promotion." Sci 331 (2011): 1565-1570.